Reflections about the optimisation of the treatment of tendinopathies with PRP

[en] Background: platelet-rich plasma (PRP) infiltration represents a recent therapy for chronic tendinopathies. However, in the literature, this treatment remains controversial. Purpose: we suggest some ideas for improving this treatment. Methods: these suggestions were based on a review of published studies and our clinical experience. Conclusion: optimizing the technique for PRP collection is paramount. Different risk factors must be corrected before infiltration and chronic tendinopathies must be carefully selected. Finally, post-infiltration rehabilitation remains absolutely critical. Standardization of the use of PRP remains necessary in order to optimize the results.

Disciplines :

Orthopedics, rehabilitation & sports medicine

Author, co-author :

Kaux, Jean-François ; Université de Liège - ULiège > Département des sciences de la motricité > Département des sciences de la motricité

Bouvard, Marc

LECUT, Christelle ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie biologique et immuno hématologie

Oury, Cécile ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : Génétique humaine

GOTHOT, André ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie biologique et immuno hématologie

Mikel, Sanchez

Crielaard, Jean-Michel ; Université de Liège - ULiège > Département des sciences de la motricité > Evaluation et entraînement des aptitudes physiques

Language :

English

Title :

Reflections about the optimisation of the treatment of tendinopathies with PRP

Publication date :

March 2015

Journal title :

Muscles, Ligaments and Tendons Journal

eISSN :

2240-4554

Publisher :

C I C Edizioni Internazionali, Roma, Italy

Volume :

Issue :

1 (eCollection 2015 Jan-Mar)

Pages :

1-4

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 30 April 2015

Statistics

Number of views

126 (22 by ULiège)

Number of downloads

241 (10 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Smets F, Croisier JL, Forthomme B, Crielaard JM, Kaux J F. Applications cliniques du Plasma riche en plaquettes (PRP) dans les lésions tendineuses: revue de la littérature. Science & Sport. 2012;27:141-153.
Kaux JF, Drion PV, Colige A, Pascon F, Libertiaux V, Hoffmann A, et al. Effects of platelet-rich plasma (PRP) on the healing of Achilles tendons of rats. Wound Repair Regen. 2012;20:748-756.
Kaux JF, Crielaard JM. Platelet-rich plasma application in the management of chronic tendinopathies. Acta Orthop Belg. 2013;79(1):10-15.
Andia I, Latorre PM, Gomez MC, Burgos-Alonso N, Abate M, Maffulli N. Platelet-rich plasma in the conservative treatment of painful tendinopathy: a systematic review and meta-analysis of controlled studies. Br Med Bull. 2014;110(1):99-115.
de Vos RJ, Windt J, Weir A. Strong evidence against platelet-rich plasma injections for chronic lateral epicondylar tendinopa-thy: a systematic review. Br J Sports Med. 2014;48(12):952-956.
Padulo J, Oliva F, Frizziero A, Maffulli N. Muscles, Ligaments and Tendons Journal. Basic principles and recommendations in clinical and field science. MLTJ. 2013;4:250-252.
Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte-and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27(3):158-167.
Kaux JF, Le Goff C, Seidel L, Peters P, Gothot A, Albert A, et al. Comparative study of five techniques of preparation of platelet-rich plasma. Pathol Biol (Paris). 2011;59(3):157-160.
Kaux JF, Le Goff C, Renouf J, Peters P, Lutteri L, Gothot A, et al. Comparison of the platelet concentrations obtained in platelet-rich plasma (PRP) between the GPS II and GPS III systems. Pathol Biol (Paris). 2011;59(5):275-277.
Malgoyre A, Bigard X, Alonso A, Sanchez MFK. Variabilité des compositions cellulaire et moléculaire des extraits de concentrés plaquettaires (platelet-rich plasma, PRP). Journal de Traumatologie du Sport. 2012;29:236-240.
Weibrich G, Kleis WK, Hitzler WE, Hafner G. Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: a technical report. Int J Oral Maxillofac Implants. 2005;20(1): 118-123.
Anitua E. What is PRGF? In: Anitua E, editor. A biological approach to implantology. Vittoria. 2009;55-66.
Lopez-Vidriero E, Goulding KA, Simon DA, Sanchez M, Johnson DH. The use of platelet-rich plasma in arthroscopy and sports medicine: optimizing the healing environment. Arthroscopy. 2010;26(2):269-278.
McCarrel TM, Minas T, Fortier LA. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg Am. 2012;94(19):e143(1-8).
Moog R, Zeiler T, Heuft HG, Stephan B, Fischer EG, Kretschmer V, et al. Collection of WBC-reduced single-donor PLT concentrates with a new blood cell separator: results of a multicenter study. Transfusion. 2003;43(8):1107-1114.
Kaux JF, Croisier JL, Bruyere O, et al. One injection of platelet-rich plasma associated to a submaximal eccentric protocol to treat chronic jumper's knee. J Sports Med Phys Fitness. 2014.
Anitua E, Sanchez M, Prado R, Orive G. The type of platelet-rich plasma may influence the safety of the approach. Knee Surg Sports Traumatol Arthrosc. 2012;22(7):1708-1709.
Intravia J, Allen DA, Durant TJ, McCarthy MB, Russell R, Beitzel K, et al. In vitro evaluation of the anti-bacterial effect of two preparations of platelet rich plasma compared with cefa-zolin and whole blood. Muscles, Ligaments and Tendons Journal. 2014;4(1):79-84.
Ahuja KD, Thomas GA, Adams MJ, Ball MJ. Postprandial platelet aggregation: effects of different meals and glycemic index. Eur J Clin Nutr. 2012;66(6):722-726.
Geerts SO, Nys M, De MP, Charpentier J, Albert A, Legrand V, et al. Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity. J Periodontol. 2002;73(1):73-78.
Laffan M, Manning R. Investigation of haemostasis. In: Lewis SM, Brain BJ, Bates I, editors. Practical haematology. 10th ed. London: Churchill Livingstone. 2006;380-440.
Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259-2272.
Harrison P, Mackie I, Mumford A, Briggs C, Liesner R, Winter M, et al. Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol. 2011;155(1):30-44.
Cattaneo M, Cerletti C, Harrison P, Hayward CP, Kenny D, Nugent D, et al. Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH. J Thromb Haemost. 2013.
Born GV, Cross MJ. The Aggregation of Blood Platelets. J Physiol. 1963;168:178-195.
Greinacher A. Platelet activation by heparin. Blood. 2011; 117(18):4686-4687.
Kaux JF, Forthomme B, Le Goff C, Crielaard JM, Croisier JL. Current opinion on tendinopathy. Journal of Sports Science and Medicine. 2011;10:238-253.
Kirchgesner T, Larbi A, Omoumi P, Malghem J, Zamali N, Manelfe J, et al. Drug-induced tendinopathy: From physiology to clinical applications. Joint Bone Spine. 2014.
Chen SK, Lu CC, Chou PH, Guo LY, Wu WL. Patellar tendon ruptures in weight lifters after local steroid injections. Arch Orthop Trauma Surg. 2009;129(3):369-372.
Fichez O. Bonnes et mauvaises indications de l'injection de PRP dans les tendinopathies chroniques du sportif. In: Bard H, Bianchi S, Brasseur JL, Djian P, Guerini H, Lapègue F, et al., editors. Le tendon et son environnement: Sauramps Médical. 2013;243-252.
Loftus ML, Endo Y, Adler RS. Retrospective analysis of postinjection ultrasound imaging after platelet-rich plasma or autologous blood: observational review of anatomic distribution of injected material. AJR Am J Roentgenol. 2012;199(4):W501-505.
Engebretsen L, Steffen K, Alsousou J, Anitua E, Bachl N, Dev-ilee R, et al. IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med. 2010;44(15): 1072-1081.
Bausset O, Magalon J, Giraudo L, Louis ML, Serratrice N, Frere C, et al. Impact of local anaesthetics and needle calibres used for painless PRP injections on platelet functionality. Muscles, ligaments and tendons journal. 2014;4(1):18-23.
Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225-228.
Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evi-dence-based approach. PM R. 2011;3(3):226-250.
Kaux JF, Forthomme B, Namurois MH, Bauvir P, Defawe N, Delvaux F, et al. Description of a standardized rehabilitation program based on sub-maximal eccentric following a platelet-rich plasma infiltration for jumper's knee. Muscles, Ligaments and Tendons Journal. 2014;4(1):85-89.
Virchenko O, Aspenberg P. How can one platelet injection after tendon injury lead to a stronger tendon after 4 weeks? Interplay between early regeneration and mechanical stimulation. Acta Orthop. 2006;77(5):806-812.
Kaux JF, Drion P, Libertiaux V, Colige A, Hoffmann A, Nusgens B, et al. Eccentric training improves tendon biomechanical properties: a rat model. J Orthop Res. 2013;31(1):119-124.
Clifford AM, Harrington E. The effect of patellar taping on squat depth and the perception of pain in people with anterior knee pain. Journal of human kinetics. 2013;37:109-117.
Kaux JF, Bruyere O, Croisier JL, et al. One-year follow-up of platelet-rich plasma infiltration to treat chronic upper patellar tendinopathies. Acta Orthop Belg. In Press.
Dallaudiere B, Meyer P, Hummel V, Perozziello A, Peuchant A, Moreau-Durieux MH, et al. Efficacy of second intra-tendi-nous platelet-rich-plasma injection in case of incomplete response of the first injection: three-year follow up experience. Diagnostic and interventional imaging. 2013;94(9):871-877.
Kaux JF, Croisier JL, Forthomme B, et al. Using platelet-rich plasma to treat jumper's knees: exploring the effects of a second closely-timed infiltration. J Sci Med Sport. In Press.
Cap AP, Perkins JG. Lyophilized platelets: challenges and opportunities. J Trauma. 2011;70 (5 Suppl):S59-60.
Jonsdottir-Buch SM, Lieder R, Sigurjonsson OE. Platelet lysates produced from expired platelet concentrates support growth and osteogenic differentiation of mesenchymal stem cells. PLoS One. 2013;8(7):e68984.
Ben Azouna N, Jenhani F, Regaeya Z, Berraeis L, Ben Oth-man T, Ducrocq E, et al. Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Stem cell research & therapy. 2012; 3(1):6.